Company profile: Biora Therapeutics
1.1 - Company Overview
Company description
- Provider of biotechnology as a biotech company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biora Therapeutics
Elucida Oncology
HQ: United States
Website
- Description: Provider of targeted C'Dot Drug Conjugates (CDCs) for patients with primary solid tumor and metastatic cancer. Ultra-small CDC nanoparticles penetrate tumors, carry high drug payloads, and clear rapidly via kidneys (Target or Clear) to reduce systemic exposure and off-target toxicity. Pipeline includes ELU001, a CDC targeting folate receptor alpha in clinical trials; ELU002; and surface chemistry for toxic payloads and radionuclides.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elucida Oncology company profile →
Kaleo
HQ: United States
Website
- Description: Provider of specialty pharmaceutical combination drug/device products and auto-injectors, including the Aerio gas-powered auto-injector platform (single, dual container, dual chamber); AUVI-Q and ALLERJECT epinephrine devices for severe allergic reactions; Naloxone Auto-Injector 10 mg for military and chemical incident responders; Pralidoxime Chloride Auto-Injector; and a patient assistance program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kaleo company profile →
OnDosis
HQ: Sweden
Website
- Description: Provider of flexible, individualized dosing of oral medicines via a Dosage Manager delivering micro-unit forms (granules, pellets, mini-tablets) with accurate dosing, plus connected services: patient app, cloud platform, and physician interface for remote monitoring, adherence support, physician-patient communication, secure data exchange, regulatory compliance, and third-party integrations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OnDosis company profile →
Lypro Bio
HQ: United States
Website
- Description: Provider of NanoDisk drug delivery technology to increase solubility and bioavailability of hydrophobic drugs, with applications in cancer (curcumin and all-trans retinoic acid for glioblastoma multiforme and mantle cell lymphoma), infectious diseases (amphotericin B for Leishmania major and Aspergillosis), and neurodegenerative disease research; also offers Ambigent, an antifungal reagent for high-value cell cultures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lypro Bio company profile →
Stratagent Life Sciences
HQ: United States
Website
- Description: Provider of specialty drug therapies that are painless and non-invasive for various diseases, developing alternatives to injected treatments based on proprietary microjet technology to deliver large and small therapeutic molecules without a device penetrating into or through the skin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stratagent Life Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biora Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biora Therapeutics
2.2 - Growth funds investing in similar companies to Biora Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biora Therapeutics
4.2 - Public trading comparable groups for Biora Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →